Publications

Availability and affordability of treatment for Human African Trypanosomiasis.

Abstract

Human African Trypanosomiasis (HAT) is a re-emerging disease whose usual treatments are becoming less efficient because of the increasing parasite resistance.

Etchegorry MG Helenport JP Pecoul B Jannin J Legros D
Tropical medicine & international health : TM & IH 2001 Nov ; 6(11); 957-9. doi: . Epub 2002 01 16

[Detection of meningococcal meningitis epidemics in Africa: a new recommendation].

Abstract

In sub-Saharan Africa, the control of meningococcal meningitis epidemics relies on early epidemic detection and mass vaccination. However, experience shows that interventions are often initiated too late to have a significant impact on the epidemic.

Lewis R Nathan N Communier A Varaine F Fermon F Chabalier FD Rosenstein N Djingarey M Diarra L Yada A Tikhomirov E Santamaria M Hardiman M Leg D
Sante (Montrouge, France) ; 11(4); 251-5. doi: . Epub 2002 04 29

Timely detection of meningococcal meningitis epidemics in Africa.

Abstract

BACKGROUND: Epidemics of meningococcal disease in Africa are commonly detected too late to prevent many cases. We assessed weekly meningitis incidence as a tool to detect epidemics in time to implement mass vaccination.

Lewis R Nathan N Diarra L Belanger F Paquet C
Lancet (London, England) 2001 Jul 28; 358(9278); 287-93. doi: 10.1016/S0140-6736(01)05484-8. Epub 2001 08 23

Rapid assessment of population size by area sampling in disaster situations.

Abstract

In the initial phase of a complex emergency, an immediate population size assessment method, based on area sampling, is vital to provide relief workers with a rapid population estimate in refugee camps.

Brown V Jacquier G Coulombier D Balandine S Belanger F Legros D
Disasters 2001 Jun ; 25(2); 164-71. doi: . Epub 2001 07 26

Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.

Abstract

Culture adapted T. b. gambiense isolated from Northwest Uganda were exposed to 0.001-0.14 microg/ml melarsoprol or 1.56-100 microg/ml DL-alpha-difluoromethylornithine (DFMO).

Matovu E Enyaru JC Legros D Schmid C Seebeck T Kaminsky R
Tropical medicine & international health : TM & IH 2001 May ; 6(5); 407-11. doi: . Epub 2001 06 28
Salignon P Cabrol JC Liu J Legros D Brown V Ford N
Lancet (London, England) 2000 Nov 18; 356(9243); 1762. doi: 10.1016/S0140-6736(00)03217-7. Epub 2000 12 14